Actinogen Medical Limited (ACW, formerly Actinogen Limited) is an ASX-listed biotechnology company developing innovative treatments for Alzheimer’s disease and the cognitive decline associated with neurodegenerative diseases and metabolic diseases, like Type 2 diabetes. It focusses on the development of Xanamem, a novel treatment for Alzheimer’s disease and the cognitive deficiency associated with other neurological and metabolic diseases within Australia.
Actinogen Medical Limited operators in Health Care sector and under industry of Biotechnology. The company website is: http://www.actinogen.com.au.
You can also check out dividend history for similar stocks in the same sector as follows:
ACW Dividend Dates
Please click the table header to sort the data.
No Dividend Dates Found